| Date Filed | Type | Description |
| 08/25/2023 |
SC 13D/A
| NVX Holdings, Inc. reports a 41.1% stake in GoHealth, Inc. |
| 08/25/2023 |
SC 13D/A
| Centerbridge Associates III, L.P. reports a 64.2% stake in GoHealth, Inc. |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 06/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/19/2023 |
SC 13D/A
| Centerbridge Associates III, L.P. reports a 66.3% stake in GoHealth, Inc. |
| 05/19/2023 |
SC 13D/A
| NVX Holdings, Inc. reports a 42.3% stake in GoHealth, Inc. |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
8-K
| Quarterly results |
| 03/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Amendment No. 10 to the Credit Agreement, among Norvax, LLC, as borrower, Owl Rock Capital Corporation, as administrative agent, collateral agent and required lenders",
"Amendment No. 10 to the Credit Agreement, among Norvax, LLC, as borrower, Owl Rock Capital Corporation, as administrative agent, collateral agent and required lenders" |
|
| 03/16/2023 |
8-K
| Quarterly results |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 2% stake in GoHealth Inc. Class A |
| 01/19/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 01/13/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 01/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/12/2022 |
SC 13D/A
| CCP III Cayman GP Ltd. reports a 66.3% stake in GoHealth, Inc. |
| 12/07/2022 |
8-K
| Quarterly results |
| 12/02/2022 |
SC 13D/A
| CCP III Cayman GP Ltd. reports a 64.5% stake in GoHealth, Inc. |
| 11/25/2022 |
SC 13D
| CCP III Cayman GP Ltd. reports a 62.3% stake in GoHealth, Inc. |
| 11/25/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/22/2022 |
8-K
| Quarterly results |
| 11/18/2022 |
8-K
| Quarterly results |
| 11/15/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/10/2022 |
8-K
| Quarterly results |
| 10/25/2022 |
8-K
| Quarterly results |
| 09/26/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Certificate of Designations of Series A Convertible Perpetual Preferred Stock of GoHealth, Inc",
"Certificate of Designations of Series A-1 Convertible Non-Voting Perpetual Preferred Stock of GoHealth, Inc",
"Investment Agreement among GoHealth, Inc. and the purchasers identified therein",
"Registration Rights Agreement among GoHealth, Inc. and the persons identified therein",
"Amendment No. 2 to the Second Amended and Restated Limited Liability Company Agreement of GoHealth Holdings, LLC",
"GoHealth Receives $50 Million Strategic Investment to Support Long-Term Growth Opportunities" |
|
| 09/19/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 09/15/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/06/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 08/16/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/15/2022 |
8-K
| Quarterly results |
|